FVC and DLCO evolution after initiation of antifibrotics as prognostic factors in IPF2023-10-270 PRE AI MMarie Vermant TTinne Goos NN. Veyt SStefan Gogaert MMarianne Carlon NNico De Crem LLaurens De Sadeleer EEllen De Langhe AAdriana Dubbeldam BBart Vanaudenaerde EErik Verbeken JJohny Verschakelen BBirgit Weynand JJonas Yserbyt PPatrick Verschueren JJoseph Jacob WWim Wuyts DOI:10.1183/13993003.congress-2023.PA5159OriginalOriginal request for helpShareSaveAbstract En